In a Friday announcement, Fiat Chrysler said that it is recalling nearly 1.1 million vehicles due to a transmission shifter issue. The automaker said that the problem which has resulted in the recall can cause the affected vehicles to roll away unexpectedly, thereby posing a potential risk of injury.
The recall announced by Fiat Chrysler affects nearly 811,590 cars and SUVs in the US; and around 300,000 vehicles in Canada, Mexico, and other international markets. The transmission shifter problem leading to the recall has reportedly caused 41 injuries in the US.
The vehicles affected by the recall include Dodge Charger and Chrysler 300 sedans from model years 2012 to 2014; and Jeep Grand Cherokee SUVs from model years 2014 and 2015.
About the issue prompting Fiat Chrysler to announce the latest recall, the National Highway Traffic Safety Administration (NHTSA) documents have revealed that the transmission shifters in the under-recall vehicles are unreasonably difficult to operate.
In the documents, the NHTSA specifically said about the transmission issue affecting the recalled Fiat Chrysler vehicles: "The shifter is not intuitive and provides poor tactile and visual feedback to the driver, increasing the potential for unintended gear selection."
On Wednesday, European competition authorities unveiled charges against Alphabet Inc.'s Google subsidiary over its widely-used Android mobile operating system. According to the authorities, the strategies which enable Google to make money from...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In a Tuesday announcement, Supergiant Games studio’s...
According to a CNN report, the Federal Investigation...
Electric vehicle manufacturer Tesla has said in a recent...
In an advisory published last Thursday, the US Computer...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).